-
June 28: The Week in Cancer News
A study indicates that many African Americans who could benefit from lung cancer screening are not eligible, and an oncologist writes about his experiences with medical aid in dying.
by Kate Yandell
-
Cancer Care on a Native American Reservation
For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.
by Kate Yandell
-
Walking Back From Cancer
An American expat in Norway describes how a favorite walking trail aided him during treatment and recovery.
by Steven Ford
-
June 21: The Week in Cancer News
A study shows that more than a third of U.S. cancer survivors experience chronic pain, and the U.S. Food and Drug Administration approves another immunotherapy for treatment of small cell lung cancer.
by Kate Yandell
-
Proton Therapy Is Associated With Reduced Side Effects
When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.
by Sue Rochman
-
June 14: The Week in Cancer News
A physician writes about the long-term effects of her treatment for Hodgkin lymphoma in the 1960s, and the U.S. Food and Drug Administration approves an immunotherapy drug as an initial treatment for metastatic head and neck cancer.
by Kate Yandell
-
So You Want to Serve on a Scientific Review Panel?
Cancer patient advocates who review research proposals can provide valuable perspective.
by Bob Riter, Monica Vakiner and Carole Baas
-
June 7: The Week in Cancer News
A study finds that a targeted therapy approved to treat advanced breast cancer lengthens survival, and data indicate that Medicaid expansion has helped ease racial disparities in access to cancer care.
by Kate Yandell
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff